HGP Advises Intelligent Medical Objects (IMO) in Acquisition of Melax TechnologiesMay 22, 2023
Intelligent Medical Objects (IMO), a leading provider of clinical terminology management and data quality solutions for healthcare, announced today that it has acquired Melax Technologies, Inc. (Melax Tech). Melax Tech empowers the healthcare and life sciences industries through use of Artificial Intelligence (AI) and Natural Language Processing (NLP) technologies to extract information from biomedical textual data to solve real-world problems. The acquisition of Melax Tech will enhance IMO’s portfolio of healthcare data solutions and enable IMO to expand its offerings to various segments in the healthcare market to tackle diverse problems like improving clinical and administrative workflows, clinical research, and patient outcomes.
“Today marks an exciting moment for IMO as we complete our first acquisition,” said Ann Barnes, Chief Executive Officer at IMO. “Combining Melax Tech’s analytics and NLP capabilities with IMO’s clinical terminology and data quality platform will enable healthcare organizations to have a more comprehensive solution for both clinical operation and research. The acquisition will also help extend our state-of-the-art capabilities to payer, pharmaceutical, and life science companies.”
“We are thrilled to join forces with IMO and combine our NLP expertise with their clinical terminology and knowledge management solutions,” said Andre Pontin, CEO of Melax Tech. “Together, we will be able to offer healthcare organizations a powerful suite of solutions that will enable them to improve patient outcomes and reduce costs.”
“HGP was instrumental in helping Intelligent Medical Objects complete its first acquisition," said Shahab Vagefi, Managing Director at Thomas H. Lee Partners (THL), a premier private equity firm that acquired IMO in 2022. “The team played a pivotal role in the proprietary M&A process and leveraged their exclusive relationships with the target to help consummate the transaction. HGP’s partnership was invaluable, and we look forward to continuing our work together.”
To read more, visit the press release here.
“HGP was instrumental in helping IMO complete its first acquisition. The team played a pivotal role in the proprietary M&A process and leveraged their exclusive relationships with the target to help consummate the transaction. HGP’s partnership was invaluable, and we look forward to continuing our work together.”
- Intelligent Medical Objects/THL, Shahab Vagefi, Managing Director